Atossa Genetics -22% on 5.8M-unit offering

Atossa Genetics (ATOS -21.9%) opens sharply lower on its plan to offer shares and warrants to raise proceeds for general corporate purposes including the development of the company’s breast health testing products.

ATOS is pricing a public offering of ~5.8M units at $2.40 each.

Comments (1)
  • pat walsh
    , contributor
    Comments (346) | Send Message
    Better get the money now just in case FDA makes company do clinical trial.
    24 Jan 2014, 10:51 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs